In this interview, Didier discusses his projects and shares advice to the community regarding what kind of activities can help foster progress in the development of rejuvenation biotechnology.
Didier is one of the most active members of the European life extension community, co-president of HEALES (Healthy Life Extension Society), vice-president of French Transhumanist Association Technoprog, and a founding member of the International Longevity Alliance.
He is also a long-term member of the local ecology movement. Didier is currently a lawyer in a Belgian federal government agency for social security. Didier is the main organizer of the biennial scientific conference Eurosymposium on Healthy Ageing, held in Brussels, Belgium.
In this interview, he focused on the extension of healthy human life and the control of technological risks, the so called “existential risks”.
We appreciate Didier taking the time to share his vision with us and we are also grateful to him for his generous contributions to the research projects hosted at Lifespan.io.
Elena has been a longevity activist and advocate since 2013, when she first started to organize educational events to make new evidence-based methods of healthy life extension more popular.
The last few years have seen Elena leading some successful projects in Russia, aimed at spreading the idea of healthy longevity among decision makers as well as the general public. Several years of lobbying resulted in the inclusion of her propositions in the strategic program documents of the Russian Federation related to the problems of the elderly. She is a co-author of the book “Aging Prevention for All” (in Russian, 2015), where, among other topics, she is sharing how to facilitate the adoption of the healthy lifestyle to promote the period of good health.
In 2015, Elena helped to shape and coordinate the successful crowdfunding campaign of the Major Mouse Testing Program – a study of Senolytic drug combinations on mouse lifespan.
In 2017 at LEAF, Elena led a successful advocacy project to include the problems of the elderly into the WHO’s 13th Programme of Work .
Previously Elena has worked as a project manager in the pharmaceutical and advertisement industries, helping to promote new drugs and therapies. This experience helped her to realize that the existing therapies were not 100% effective and could not completely stop age-related diseases – which has ignited an interest for the development of innovative therapies.
Elena graduated with a bachelor’s in both psychology and foreign languages and is now working to earn her MBA at the oldest Russian business school MIRBIS.
Researchers have published a new animal study showing that the plant flavonoid naringenin may be useful in targeting problematic senescent cells in the brain. Ribes meyeri […]
In this interview at Ending Age-Related Diseases 2020, Elena Milova of Lifespan.io and Daria Khaltourina of the International Longevity Alliance discuss whether or not aging should be considered a […]
Recently, we had the opportunity to interview Rick Kiessig, the co-founder of Kimer Med, a company developing a broad-spectrum antiviral that has the potential to destroy a wide range of viruses. […]
Dr. Oliver Medvedik and the Journal Club will be returning on September 29th at 13:00 EDT live on our Facebook page. The topic for this month is going to be a new study that implicates […]
According to new research, mutations accumulate in the mitochondrial DNA of egg cells, leading to changes in cellular metabolism, which result in reduced fertility. The […]
A new study published in Archives of Dermatological Research has shown that a novel microporous membrane can promote the regeneration of healthy human skin. Skin regeneration Skin regeneration has been a major goal for tissue engineering and regenerative […]
This week on Lifespan News, Brent Nally talks about aging and COVID-19, the effects of NMN on COVID-19 patients, a common diabetes drug that reduces inflammation in the liver, brown fat in mice, and the role that tissue engineering and regenerative medicine plays in longevity.
A group of researchers has been able to ameliorate Alzheimer-like pathologies in mice by using a microtubule-stabilizing compound [1]. Cellular highways Microtubules (MTs) are tiny pipe-like structures that are made […]
You have 3 free articles remaining this week. You can register for free to continue enjoying the best in rejuvenation biotechnology news. Already registered? Login here.
Write a comment: